Compass Pathways (CMPS) PT Raised to $17 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CMPS Hot Sheet
Price: $8.60 +0.12%
Rating Summary:
19 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 1
Rating Summary:
19 Buy, 1 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 14 | New: 1
Join SI Premium – FREE
Morgan Stanley analyst Judah C. Frommer raised the price target on Compass Pathways (NASDAQ: CMPS) to $17.00 (from $16.00) while maintaining a Overweight rating.
You May Also Be Interested In
- RBC Capital on Compass Pathways (CMPS): 'We See an Opportunity to Buy on Weakness'
- Compass Pathways (CMPS) PT Lowered to $10 at Wells Fargo
- Smith & Nephew PLC. (SN:LN) (SNN) PT Raised to GBP12.10 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
